Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04466800
Other study ID # 35RC20_9875_RECOVER-19
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 30, 2020
Est. completion date January 13, 2023

Study information

Verified date January 2023
Source Rennes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Following the acute phase of COVID, some patients may have sequelae, such as breathing difficulties or malnutrition. We hypothesize that a functional and respiratory rehabilitation program associated with personalized nutritional care will improve quality of life, physical performance and respiratory capacities and will decrease the prevalence of malnutrition among those patients.


Description:

In France, more than 150 000 patients have been infected by the SARS-CoV-2 virus and COVID has been responsible for more than 100 000 hospitalizations. Following the acute phase of this disease, some patients may have sequelae, such as breathing difficulties or malnutrition. However, the prevalence and intensity of those sequelae still remain unknown. Thus, a functional and respiratory rehabilitation program associated with personalized nutritional care may be necessary to improve those patients' prognosis. This study aims to evaluate the effectiveness of a 4-week rehabilitation program following the acute phase of COVID. This program includes regular physical activity supervised by a physical acticity educator, a systematic malnutrition screening and a nutritional follow-up performed by a dietitian. Patients will be randomized in two groups: rehabilitation program (intervention group) or usual care (control group). Quality of life, physical performance, respiratory capacities and nutritional status will be assessed in both groups at inclusion and one month later (corresponding to the end of the rehabilitation program for the intervention group).


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date January 13, 2023
Est. primary completion date August 29, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age above 18 years - Laboratory (RT-PCR and/or serology) confirmed infection with SARS-CoV-2 - Date of first symptoms of SARS-CoV-2 infection > 4 weeks and < 4 months - Persisting functional and/or respiratory deficit and/or asthenia and/or malnutrition beyond the first 4 weeks after COVID, defined as : - Increase of mMRC (Modified Medical Research Council) score = 1 between the month before COVID and beyond the first 4 weeks after COVID and/or - Asthenia score (Pichot asthenia scale) > 22 beyond the first 4 weeks after COVID, if patient had no asthenia before COVID (asthenia score <8) and/or - Weight loss > 5% within 6 months, comparing minimum weight between the month before COVID and beyond the first 4 weeks after COVID and/or - BMI (Body Mass Index) < 20 (if age < 70 years) or < 22 (if age = 70 years) if BMI (Body Mass Index) = 20 (if age < 70 years) or = 22 (if age = 70 years) the month before COVID - Patient affiliated to social security system - Patient gave written informed consent Exclusion Criteria: - Patient unable to undergo a rehabilitation program due to comorbidities, such as major cardio-vascular disease or severe dementia - Patient currently benefiting from physiotherapy sessions, in particular motor and / or respiratory therapy and / or an exercise re-training and / or respiratory rehabilitation program - Patient living in a residential facility for dependent elderly people - Patient not speaking french - Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intervention group_rehabilitation program
Regular physical activity, supervised by a physical education educator, a systematic malnutrition screening and a nutritional follow-up performed by a dietetician. Patients will follow a 4-week rehabilitation program, comprising 3 physical activity sessions per week for 4 weeks. First sessions will be supervised by a physical activity educator and patients will perform the following sessions at home, using physical training software. The physical activity educator will call patients once a week to ensure the sessions are correctly performed and adapt the program if necessary. Patients will also undergo a nutritional assessment carried out by a dietitian at the beginning of the program. A dietitian will call patients once a week to ensure their nutritional status is appropriate.

Locations

Country Name City State
France Hôtel Dieu Paris Paris
France Centre Hospitalier de Cornouaille Quimper
France CHU Rennes Rennes
France Centre Hospitalier de Saint-Brieuc Saint-Brieuc
France Centre Hospitalier Bretagne Atlantique Vannes

Sponsors (1)

Lead Sponsor Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Impact of a multidisciplinary and personalized rehabilitation program on COVID patients's quality of life Physical component score of the Short-Form 36 health survey between the beginning and the end of the rehabilitation program (from 0 to 100; highers scores mean better outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Physical capacities Number of repeated chair rises during 3 minutes 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Physical capacities Aerobic physical capacity using Eval-DM software 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Modified Medical Research Council scale (mMRC) (from 0 to 4, highers scores mean worse outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Modified Medical Research Council scale (mMRC) (from 0 to 4, highers scores mean worse outcome) 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Modified Medical Research Council scale (mMRC) (from 0 to 4, highers scores mean worse outcome) 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Borg scale (from 0 to 10, highers scores mean worse outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Functional capacities Barthel scale (from 0 to 100, highers scores mean worse outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Functional capacities Barthel scale (from 0 to 100, highers scores mean worse outcome) 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Functional capacities Barthel scale (from 0 to 100, highers scores mean worse outcome) 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Weight loss 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Weight loss 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Weight loss 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Body mass index 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Body mass index 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Body mass index 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Muscular mass by brachial circumference or grip strength 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria SEFI® score (from 0 to 10, highers scores mean better outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria SEFI® score (from 0 to 10, highers scores mean better outcome) 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria SEFI® score (from 0 to 10, highers scores mean better outcome) 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of mortality Mortality rate 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of mortality Mortality rate 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of mortality Mortality rate 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Score of the Short-Form 36 health Survey (from 0 to 100, highers scores mean better outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Score of the Short-Form 36 health Survey (from 0 to 100, highers scores mean better outcome) 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Score of the Short-Form 36 health Survey (from 0 to 100, highers scores mean better outcome) 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life EuroQol 5 Dimensions 5 Levels surveys (from 0 to 1, highers scores mean better outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life EuroQol 5 Dimensions 5 Levels surveys (from 0 to 1, highers scores mean better outcome) 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life EuroQol 5 Dimensions 5 Levels surveys (from 0 to 1, highers scores mean better outcome) 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Proportion of patients returning to a professional activity 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Proportion of patients returning to a professional activity 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Proportion of patients returning to a professional activity 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Hospital and Anxiety Depression Scale (from 0 to 42, highers scores mean worse outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Hospital and Anxiety Depression Scale (from 0 to 42, highers scores mean worse outcome 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Hospital and Anxiety Depression Scale (from 0 to 42, highers scores mean worse outcome 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Pichot asthenia scale (from 0 to 32, highers mean worse outcome) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Pichot asthenia scale (from 0 to 32, highers mean worse outcome) 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Pichot asthenia scale (from 0 to 32, highers mean worse outcome) 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Number of consultations with the healthcare professionals 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Number of consultations with the healthcare professionals 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Number of consultations with the healthcare professionals 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Rehospitalisation rate (all causes) 1 month
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Rehospitalisation rate (all causes) 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Rehospitalisation rate (all causes) 6 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Medico-economic evaluation Incremental cost-effectiveness ratio 3 months
Secondary Impact of a multidisciplinary and personalized rehabilitation program in terms of Medico-economic evaluation Incremental cost-effectiveness ratio 6 months
Secondary Patient's opinion concerning the rehabilitation program Satisfaction questionnaire with open-ended questions (no specific scale is available) 3 months
Secondary Patient's opinion concerning the rehabilitation program Satisfaction questionnaire with open-ended questions (no specific scale is available) 6 months
See also
  Status Clinical Trial Phase
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Recruiting NCT04410510 - P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 Phase 2/Phase 3
Active, not recruiting NCT04420676 - Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection N/A
Completed NCT04419025 - Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease Phase 2
Completed NCT04425317 - Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients N/A
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Withdrawn NCT04456426 - Characteristics of Patients With COVID-19 in Meta State, Colombia
Completed NCT04526769 - Detecting SARS-CoV-2 in Tears
Suspended NCT04385771 - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation N/A
Completed NCT04425720 - Use of Remote Monitoring for COVID-19 Patient N/A
Completed NCT04419610 - RAS and Coagulopathy in COVID19 Early Phase 1
Completed NCT04546581 - Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Phase 3
Completed NCT04435327 - Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Terminated NCT04530448 - Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization Phase 4
Not yet recruiting NCT04524156 - COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2 N/A
Completed NCT04441710 - Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus
Completed NCT04357834 - WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
Not yet recruiting NCT04392427 - New Antiviral Drugs for Treatment of COVID-19 Phase 3
Terminated NCT04614025 - Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 Phase 2
Completed NCT04402957 - LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) Phase 2